INDUCTION OF UNRESPONSIVENESS TO ISLET ALLOGRAFT BY ANTI-LFA-1 MONOCLONAL-ANTIBODY TREATMENT

被引：0
|
作者：
GOTOH, M
FUKUZAKI, T
DONO, K
WADA, H
KANAI, T
MONDEN, M
YAGITA, H
OKUMURA, K
MORI, T
机构：
[1] OSAKA UNIV, SCH MED, DEPT SURG 2, SUITA, OSAKA 565, JAPAN
[2] JUNTENDO UNIV, SCH MED, DEPT IMMUNOL, TOKYO 113, JAPAN
来源：
TRANSPLANTATION PROCEEDINGS | 1993年 / 25卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：973 / 974
页数：2
相关论文
共 50 条
  • [21] Combination of anti-ICAM-1 and anti-LFA-1 monoclonal antibody therapy prolongs allograft survival in rat hind-limb transplants
    Ozer, K
    Siemionow, M
    JOURNAL OF RECONSTRUCTIVE MICROSURGERY, 2001, 17 (07) : 511 - 517
  • [22] Immunosuppression by anti-ICAM-1 and anti-LFA-1 monoclonal antibodies of free and vascularized skin allograft rejection
    Iwata, T
    Kamei, Y
    Esaki, S
    Takada, T
    Torii, S
    Yamashita, A
    Tomida, S
    Tamatani, T
    Miyasaka, M
    Yoshikai, Y
    IMMUNOBIOLOGY, 1996, 195 (02) : 160 - 171
  • [23] Anti-LFA-1 monoclonal antibody in renal transplantation: Renal function, infections, and other complications
    Spillner, J
    Kohnle, M
    Albrecht, KH
    Heemann, U
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (05) : 2163 - 2163
  • [24] Long-term survival of neonatal porcine islet xenografts co-transplanted with Sertoli cells and combined treatment with anti-LFA-1 monoclonal antibody
    Bayrack, Kevin
    Mihalicz, Dana
    Alavi, Fatemeh
    Rajotte, Ray V.
    Rayat, Gina R.
    XENOTRANSPLANTATION, 2011, 18 (05) : 292 - 292
  • [25] Islet Allograft Survival in Type 1 Diabetics Using a Calcineurin Inhibitor-Free Protocol Based on the Anti-LFA-1 Antibody Efalizumab.
    Posselt, Andrew
    Szot, G.
    Frassetto, L.
    Masharani, U.
    Kerlan, R.
    Vincenti, F.
    Fong, L.
    Tavakol, M.
    Bluestone, J.
    Hering, B.
    Stock, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 321 - 322
  • [26] Islet Transplantation in Type 1 Diabetics Using an Immunosuppressive Protocol Based on the Anti-LFA-1 Antibody Efalizumab
    Posselt, A. M.
    Bellin, M. D.
    Tavakol, M.
    Szot, G. L.
    Frassetto, L. A.
    Masharani, U.
    Kerlan, R. K.
    Fong, L.
    Vincenti, F. G.
    Hering, B. J.
    Bluestone, A.
    Stock, P. G.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 (08) : 1870 - 1880
  • [27] AN ANTI-LFA-1 MONOCLONAL-ANTIBODY INDUCES CELLULAR AGGREGATION OF HUMAN LYMPHOBLASTOID CELL-LINES AND PERIPHERAL-BLOOD LYMPHOCYTES
    YANG, J
    MATHIOUDAKIS, G
    KRUZEL, E
    ANGELO, L
    LEE, J
    PLATSOUCAS, CD
    JOURNAL OF IMMUNOLOGY, 1993, 150 (08): : A307 - A307
  • [28] Induction of unresponsiveness to islet xenografts by a short-course treatment by anti-CD4 nondepleting monoclonal antibody
    Lu, X
    Schulz, M
    Zihlmann, HR
    Borel, JF
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (02) : 552 - 553
  • [29] Treatment with anti-LFA-1 alpha monoclonal antibody selectively interferes with the maturation of CD4(-)8(+) thymocytes
    Revilla, C
    Gonzalez, AL
    Conde, C
    LopezHoyos, M
    Merino, J
    IMMUNOLOGY, 1997, 90 (04) : 550 - 556
  • [30] POTENT AND EFFECTIVE PROLONGATION BY ANTI-LFA-1 MONOCLONAL-ANTIBODY MONOTHERAPY OF NON-PRIMARILY VASCULARIZED HEART ALLOGRAFT SURVIVAL IN MICE WITHOUT T-CELL DEPLETION
    NAKAKURA, EK
    MCCABE, SM
    ZHENG, B
    SHORTHOUSE, RA
    SCHEINER, TM
    BLANK, G
    JARDIEU, PM
    MORRIS, RE
    TRANSPLANTATION, 1993, 55 (02) : 412 - 417
12345